December 2021—PixCell Medical (Yokne’am Illit, Israel) announced it has opened a U.S. subsidiary in the Denver metropolitan area. The new office aims to increase logistical and commercial support for the company’s U.S. clients and will handle order fulfilment across the country as well as provide additional clinical and technical support to customers.
“Opening a U.S. office is a significant milestone for PixCell as we continue to expand access to HemoScreen around the world,” Dr. Avishay Bransky, co-founder and CEO of PixCell Medical, said in a press statement. “We are already supplying units across Australia, Europe, and the U.S. to ensure that health care organizations can deliver lab-quality blood testing anywhere, in a timely and affordable manner. This office will allow us to better serve our growing customer base in the United States with technical, clinical, and logistical support.”
PixCell’s HemoScreen is a five-part differential CBC analyzer that is FDA cleared and CE marked for point-of-care use. The portable diagnostic device provides CBC results with 20 standard parameters, as well as comprehensive abnormal cell flagging, in five minutes.
PixCell Medical, +972-4-959-3516